共 50 条
- [31] The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement [J]. QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 1998, 91 (02): : 141 - 157
- [32] Occurrence of prostaglandin D synthase in urine of patients with immunoglobulin light chain amyloidosis (AL amyloidosis) [J]. PROSTAGLANDINS, 1996, 51 (04): : 291 - 291
- [33] Frequency of hereditary systemic amyloidosis masquerading as immunoglobulin light chain, AL (primary), amyloidosis. [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 39A - 39A
- [35] Venetoclax in Immunoglobulin Light Chain Amyloidosis: Is This the Beginning or the End? [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : 686 - 688
- [36] Hereditary systemic immunoglobulin light-chain amyloidosis [J]. BLOOD, 2015, 125 (21) : 3281 - 3286
- [37] Treatment Tolerability in Patients with Immunoglobulin Light Chain Amyloidosis [J]. AMERICAN HEALTH AND DRUG BENEFITS, 2018, 11 (08): : 430 - 437